GRK2-Mediated Crosstalk Between β-Adrenergic and Angiotensin II Receptors Enhances Adrenocortical Aldosterone Production In Vitro and In Vivo.

Autor: Pollard, Celina M.¹ cp1743@mynsu.nova.edu, Ghandour, Jennifer¹ jg2901@mynsu.nova.edu, Cora, Natalie¹ nc1174@mynsu.nova.edu, Perez, Arianna¹ ap2491@mynsu.nova.edu, Parker, Barbara M.¹ barbaramparker@gmail.com, Desimine, Victoria L.¹ vd359@mynsu.nova.edu, Wertz, Shelby L.¹ sw1541@mynsu.nova.edu, Pereyra, Janelle M.¹ jm3706@yahoo.com, Ferraino, Krysten E.¹ kf713@mynsu.nova.edu, Patel, Jainika J.¹ jp2812@mynsu.nova.edu, Lymperopoulos, Anastasios^1,2 al806@nova.edu

Publikováno v: International Journal of Molecular Sciences. 1/15/2020, Vol. 21 Issue 2, p1-12. 12p. 1 Diagram, 4 Graphs.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Correction: Maning et al. Antagonistic Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Reveal GRK5-Mediated Cardioprotection via Mineralocorticoid Receptor Inhibition. Int. J. Mol. Sci. 2020, 21 , 2868.

Autor: Maning, Jennifer, McCrink, Katie A., Pollard, Celina M., Desimine, Victoria L., Ghandour, Jennifer, Perez, Arianna, Cora, Natalie, Ferraino, Krysten E., Parker, Barbara M., Brill, Ava R., Aukszi, Beatrix, Lymperopoulos, Anastasios

Publikováno v: International Journal of Molecular Sciences; Aug2021, Vol. 22 Issue 15, p7767-7767, 1p

Nicotine-induced adrenal beta-arrestin1 upregulation mediates tobacco-related hyperaldosteronism leading to cardiac dysfunction.

Autor: Cora N; Laboratory for the Study of Neurohormonal Control of the Circulation, Department of Pharmaceutical Sciences (Pharmacology), College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328-2018, United States., Ghandour J; Laboratory for the Study of Neurohormonal Control of the Circulation, Department of Pharmaceutical Sciences (Pharmacology), College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328-2018, United States., Pollard CM; Laboratory for the Study of Neurohormonal Control of the Circulation, Department of Pharmaceutical Sciences (Pharmacology), College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328-2018, United States., Desimine VL; Laboratory for the Study of Neurohormonal Control of the Circulation, Department of Pharmaceutical Sciences (Pharmacology), College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328-2018, United States., Ferraino KE; Laboratory for the Study of Neurohormonal Control of the Circulation, Department of Pharmaceutical Sciences (Pharmacology), College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328-2018, United States., Pereyra JM; Laboratory for the Study of Neurohormonal Control of the Circulation, Department of Pharmaceutical Sciences (Pharmacology), College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328-2018, United States., Valiente R; Laboratory for the Study of Neurohormonal Control of the Circulation, Department of Pharmaceutical Sciences (Pharmacology), College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328-2018, United States., Lymperopoulos A; Laboratory for the Study of Neurohormonal Control of the Circulation, Department of Pharmaceutical Sciences (Pharmacology), College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328-2018, United States. al806@nova.edu.

Publikováno v: World journal of cardiology [World J Cardiol] 2020 May 26; Vol. 12 (5), pp. 192-202.